Selling change at Lilly: Company overhauls strategy its thousands of sales reps use to tout drugs to doctors
Eli Lilly and Co. is rolling out a new approach to selling drugs, one that aims to build deeper relationships with doctors while cutting the number of sales reps knocking on their office door. The reorganization project, dubbed “sales force of the future,” is just what the doctor ordered, according to Lilly executives. They say physicians want fewer sales calls and a deeper knowledge base from those who still stop by. “Doctors want that primarily because they’re treating patients and…